Overview
Retail Trade

Qol Holdings Co.,Ltd.

Quol Holdings Co., Ltd. operates three core business segments: a Pharmacy Business (dispensing pharmacies operated through 21 consolidated subsidiaries including Quol Co., Ltd.), a BPO Business (CSO, CRO, staffing/placement, and publishing-related services through 6 subsidiaries including ApoPlus Station Co., Ltd.), and a Pharmaceutical Manufacturing Business (manufacture and sale of pharmaceuticals through 2 subsidiaries including Daiichi Sankyo Espha Co., Ltd.). The company serves patients, healthcare professionals, and pharmaceutical manufacturers across Japan. Its integrated healthcare platform spanning dispensing, outsourcing services, and drug manufacturing distinguishes it from pure-play pharmacy operators.

Market Cap
¥88.9B
US$567M
EV
¥104B
US$661M
Stock¥2,367▲+0.55%
US$1 = ¥156.80 (2026-10-23)
LTM EV/EBITDA
4.5
x
LTM EV/EBIT
5.8
x
LTM PER
10.4
x
LTM PBR
1.5
x
Stock vs TOPIX (1Y, base=100)vs TOPIX ▼-3.0%pt
10012
Oct 24, 25 – Oct 23, 26StockTOPIX
1Feb 6, 26Q3 earnings disappointment
2Aug 10, 26Q1 earnings: operating profit +72.1%, net profit +61.7%, 37.5% progress rate
MC → EV Bridge
88.9BUS$567MMarket Cap38.5BUS$246M+ Debt25.7BUS$164M− Cash0.16BUS$1.04M− Inv. Sec.2.09BUS$13.4M+ NCI104BUS$661MEV
AI Briefing
Generating insights…
Performance & Balance
Revenue 5Y (¥B)
166US$1.06B'22/3170US$1.08B'23/3180US$1.15B'24/3264US$1.68B'25/3291US$1.85B'26/3
EBITDA 5Y (¥B)
11.4US$72.8M'22/311.2US$71.3M'23/310.2US$64.9M'24/317.5US$112M'25/320.4US$130M'26/3
Net Income 5Y (¥B)
5.49US$35.0M'22/35.66US$36.1M'23/34.88US$31.1M'24/35.16US$32.9M'25/37.41US$47.2M'26/3
Capital Structure
61%
39%
EquityD/E 0.65xDebt
Liquidity vs Debt 5Y (¥B)▼ Net Debt
CashInv. Sec.Debt
16.8US$107M22.5US$143M'22/318.9US$121M22.1US$141M'23/327.4US$175M31.6US$202M'24/326.9US$171M41.3US$263M'25/321.6US$138M37.7US$240M'26/3
Shareholders
Top 10 hold 62.4%
1
MEDIPAL HOLDINGS CORPORATION
20.17%
2
MSIP CLIENT SECURITIES (Standing Proxy: Morgan Stanley MUFG Securities Co., Ltd.)
10.06%
3
The Master Trust Bank of Japan, Ltd. (Trust Account)
6.17%
4
Employee Stock Ownership Association
4.72%
5
Kei NAKAMURA
4.36%
6
Morgan Stanley MUFG Securities Co., Ltd.
4.18%
7
UBS AG SINGAPORE-CLIENT ACCOUNT JSAT (Standing Proxy: Citibank, N.A., Tokyo Branch)
3.70%
8
DAIICHI SANKYO COMPANY,LIMITED
3.47%
9
Medipal Insurance Service Co., Ltd.
2.93%
10
BNP PARIBAS LUXEMBOURG/2S/JASDEC/FIM/LUXEMBOURG FUNDS/UCITS ASSETS (Standing Proxy: The Hongkong and Shanghai Banking Corporation Limited, Tokyo Branch)
2.60%
Management
12 officers
Kei NAKAMURA
Representative Director, President
Apr 1992 Joined Daiichi Pharmaceutical Co., Ltd. (currently Daiichi Sankyo Company, Limited) Oct 2001 Joined the Company Jun 2003 Director, General Manager, President's Office Oct 2004 General Manager, Development Division Jun 2005 Managing Director Jun 2007 Representative Director, Executive Vice President Jun 2016 Representative Director, President (current)
1970-01-19
Takayoshi ISHII
Representative Director, Senior Managing Director
Apr 1985 Joined Shionogi & Co., Ltd. Jun 2014 Joined the Company; Deputy General Manager, Business Strategy Division Oct 2014 General Manager, Business Planning Department Apr 2015 Executive Officer; General Manager, Business Strategy Division Apr 2016 General Manager, Business Planning Division Oct 2016 Senior Executive Officer Jun 2017 Director Oct 2018 General Manager, President's Office Apr 2019 Managing Director Jul 2020 General Manager, Business Strategy Division Apr 2021 Representative Director, Managing Director Apr 2023 Representative Director, Senior Managing Director (current) Apr 2026 General Manager, Business Strategy Division (current)
1961-10-26
Kiyonobu FUKUMITSU
Representative Director, Managing Director
Apr 1991 Joined The Dai-Ichi Kangyo Bank, Ltd. (currently Mizuho Financial Group, Inc.) Sep 2002 Joined the Company Apr 2005 Executive Officer Apr 2008 Senior Executive Officer; General Manager, Administration Division Jun 2009 Director Apr 2013 General Manager, Business Strategy Division; concurrently General Manager, Business Strategy Department Apr 2014 General Manager, Business Strategy Division Jun 2014 Managing Director Oct 2018 General Manager, Management Department Jul 2020 General Manager, Management Division Oct 2020 Representative Director, Managing Director (current) Jun 2023 Director, Shiba Corporate Association (Public Interest Incorporated Association) (current) Apr 2026 General Manager, Management Division (current)
1968-05-16
Shinobu KARASAWA
Managing Director
Oct 1985 Joined Nagashima Kaisei Hospital, Minewakai Medical Corporation Jul 1986 Registered as Pharmacist Mar 1999 Joined the Company Apr 2010 Executive Officer; General Manager, Kanto No. 1 Business Department, Pharmacy Business Division Apr 2015 Senior Executive Officer; General Manager, Kanto No. 1 Pharmacy Business Division, East Japan Branch May 2018 Director and Vice President, QOL Spin-off Preparation Co., Ltd. (currently QOL Co., Ltd.) Oct 2020 Representative Director, President, QOL Co., Ltd. (current) Jun 2022 Director of the Company May 2024 Vice Chairman, Japan Association of Insurance Pharmacies (current) Jun 2025 Managing Director of the Company (current) Apr 2026 General Manager, Pharmacy Business Division (current)
1961-12-25
Yutaka TOGASHI
Director
Apr 1994 Joined Kinki Nippon Tourist Co., Ltd. (currently KNT-CT Holdings Co., Ltd.) Aug 2000 Joined the Company Apr 2007 General Manager, General Affairs Department Apr 2012 Executive Officer Apr 2014 General Manager, Administration Division Apr 2015 Deputy General Manager, Administration Division; concurrently General Manager, Human Resources and Development Department Apr 2017 General Manager, Administration Division May 2018 Director, QOL Spin-off Preparation Co., Ltd. (currently QOL Co., Ltd.) Oct 2018 Manager in charge, Management Department of the Company; concurrently General Manager, Administration Division, QOL Co., Ltd. Oct 2019 Managing Director, QOL Co., Ltd. Jul 2020 Director of the Company (current); General Manager, Human Resources Division; in charge of Public Relations Jun 2025 General Manager, Human Resources Planning Department Apr 2026 General Manager, Human Resources and Education Division (current); concurrently General Manager, Human Resources Planning Department (current)
1973-04-22
Kei IMAI
Director
Apr 2002 Joined the Company Jun 2002 Registered as Pharmacist Jul 2012 General Manager, Hokkaido Business Department, Hokkaido Tohoku Pharmacy Business Division Aug 2016 General Manager, Hospitaltown Concept Promotion Department Oct 2018 General Manager, Affiliated Companies Group, President's Office Sep 2020 General Manager, Business Planning Department Jun 2024 Director (current) Apr 2026 General Manager, Business Planning Division (current)
1978-07-03
Jun KAWAGUCHI
Director
Feb 2000 Joined Lincoln Motors Co., Ltd. Nov 2005 Joined the Company Apr 2019 General Manager, Store Construction Department, Pharmacy Support Division, QOL Co., Ltd. Oct 2020 Manager in charge, Management Department of the Company; concurrently General Manager, General Affairs and Legal Affairs Department, Management Division, QOL Co., Ltd. Oct 2022 General Manager, Disaster Response Department, Management Function of the Company Apr 2024 General Manager, General Affairs and Legal Affairs Department; concurrently General Manager, Management Division, QOL Co., Ltd. Jun 2024 Director, QOL Co., Ltd. Apr 2026 General Manager, General Affairs and Disaster Response Division (current); concurrently General Manager, General Affairs and Legal Affairs Department (current); concurrently General Manager, Disaster Response Department (current) Jun 2026 Director (assumed office)
1977-10-31
Toshiko KUBOKI
Outside Director
Apr 1987 Registered as Attorney-at-Law; joined Yamasaki Law and Patent Office Apr 1993 Opened Ohno & Kuboki Law Office Aug 2003 Opened Kuboki Law Office; Managing Attorney (current) Apr 2012 Visiting Professor, Chuo University Law School (current) Jun 2015 Outside Director of the Company (current) Jun 2016 Outside Audit and Supervisory Board Member, Citizen Holdings Co., Ltd. (currently Citizen Watch Co., Ltd.) Jun 2019 Outside Director, Citizen Watch Co., Ltd. (current) Apr 2023 Vice President, Tokyo Medical and Dental University (currently Institute of Science Tokyo) Jun 2023 Outside Director (Audit and Supervisory Committee Member), Asahi Organic Chemicals Industry Co., Ltd. (current) Oct 2024 Vice Executive Director, Institute of Science Tokyo Apr 2026 Special Assistant to the President and Chancellor, Institute of Science Tokyo (current)
1960-02-26
Koji YAMAMOTO
Outside Director
Jun 1996 Registered as Certified Tax Accountant Oct 2000 Opened Yamamoto Accounting Office; Principal (current) Jun 2001 Audit and Supervisory Board Member of the Company Apr 2007 Established United Co., Ltd.; Representative Director (current) Jun 2019 Outside Director of the Company (current)
1968-01-21
Yasutoshi MORI
Outside Director (Audit and Supervisory Committee Member)
Sep 1992 Joined Ohara Accounting School; Instructor, Tax Accountant Course Oct 1997 Joined Katsushima Toshiaki Tax Accountant Office (currently Deloitte Tohmatsu Tax Co.) May 2003 Joined Kojimachi Tax Accountant Corporation Jul 2003 Registered as Certified Tax Accountant Jun 2004 Partner, Kojimachi Tax Accountant Corporation (current) Jun 2023 Outside Director (Audit and Supervisory Committee Member) of the Company (current)
1972-03-09
Motoyuki MIYAZAKI
Outside Director (Audit and Supervisory Committee Member)
Apr 1981 Joined The Dai-Ichi Kangyo Bank, Ltd. (currently Mizuho Financial Group, Inc.) Feb 1994 Seconded to The CIT Group, Inc. Mar 2001 Registered as Certified Public Accountant Apr 2001 Joined Chuo Aoyama Audit Corporation Jul 2007 Auditor, ABL Association (current) Jul 2007 Partner, Tohmatsu Audit Corporation (currently Deloitte Touche Tohmatsu LLC) Oct 2017 Joined True Burg Group Holdings Co., Ltd. as Executive Officer Jan 2018 Director and Vice President, True Burg Group Holdings Co., Ltd. Jun 2019 Outside Audit and Supervisory Board Member of the Company Apr 2021 Director, Regional Revitalization Inbound Council (General Incorporated Association) Jun 2021 Outside Director (Audit and Supervisory Committee Member) of the Company (current)
1956-10-17
Kazuo ISHII
Director (Audit and Supervisory Committee Member)
Apr 1988 Joined Kawasaki Heavy Industries, Ltd. Oct 1994 Joined Tohmatsu & Co. Audit Corporation (currently Deloitte Touche Tohmatsu LLC) Aug 1998 Registered as Certified Public Accountant Oct 2012 Joined Medipro Co., Ltd. (currently the Company) Apr 2013 Manager in charge, Finance Department, Administration Division, QOL Co., Ltd. (currently the Company) Oct 2018 General Manager, Internal Audit Department of the Company Apr 2019 Manager in charge, Management Division of the Company; concurrently General Manager, Finance Department, Management Division, QOL Co., Ltd. Jun 2022 Audit and Supervisory Board Member, QOL Co., Ltd. Jun 2023 Director (Audit and Supervisory Committee Member) of the Company (current)
1964-04-02
Large Shareholding Reports
Morgan Stanley & Co. International plc
2026-10-21
4.79%
Morgan Stanley MUFG Securities Co., Ltd.
2026-10-06
4.28%→4.19%
Annual report (as of 2026-03-31): 4.18%
Morgan Stanley & Co. International plc
2026-09-24
7.16%→5.11%
Morgan Stanley & Co. International plc
2026-09-18
7.13%→7.16%
Morgan Stanley & Co. International plc
2026-09-17
7.14%→7.13%
Morgan Stanley & Co. International plc
2026-09-14
7.14%
Kei NAKAMURA
2026-09-02
4.41%→4.29%
Annual report (as of 2026-03-31): 4.36%
Morgan Stanley & Co. International plc
2026-07-22
1.74%→4.08%
Morgan Stanley MUFG Securities Co., Ltd.
2026-07-17
3.81%→3.83%
Morgan Stanley & Co. International plc
2026-07-15
7.93%→7.97%
Morgan Stanley & Co. International plc
2026-07-14
0.13%→7.93%
Morgan Stanley MUFG Securities Co., Ltd.
2026-05-21
5.15%→4.69%
WILL FIELD CAPITAL PTE.LTD.
2026-04-24
17.73%→17.73%
WILL FIELD CAPITAL PTE.LTD.
2026-04-22
17.73%→17.73%
Morgan Stanley MUFG Securities Co., Ltd.
2026-04-21
5.15%
Annual report (as of 2026-03-31): 4.18%
WILL FIELD CAPITAL PTE.LTD.
2026-04-02
17.73%→17.73%
Fumiya SHINO
2026-03-26
0.45%→0.49%
Correction filing (name/detail fix only) — ratio carried over from the original filing
WILL FIELD CAPITAL PTE.LTD.
2026-03-25
17.15%→17.73%
WILL FIELD CAPITAL PTE.LTD.
2026-03-16
16.06%→17.15%
Morgan Stanley & Co. International plc
2026-03-05
8.56%→1.67%
WILL FIELD CAPITAL PTE.LTD.
2026-03-05
14.97%→16.06%
Morgan Stanley & Co. International plc
2026-02-19
7.01%→8.56%
WILL FIELD CAPITAL PTE.LTD.
2026-02-19
13.89%→14.97%
WILL FIELD CAPITAL PTE.LTD.
2026-02-13
12.85%→13.89%
Morgan Stanley & Co. International plc
2026-02-05
7.03%→7.01%
WILL FIELD CAPITAL PTE.LTD.
2026-01-23
11.85%→12.85%
Morgan Stanley & Co. International plc
2026-01-21
7.03%
Morgan Stanley & Co. International plc
2026-01-08
7.10%→0.46%
WILL FIELD CAPITAL PTE.LTD.
2026-01-06
10.77%→11.85%
WILL FIELD CAPITAL PTE.LTD.
2025-11-28
9.76%→10.77%
Morgan Stanley & Co. International plc
2025-11-20
7.10%
WILL FIELD CAPITAL PTE.LTD.
2025-11-10
8.69%→9.76%
Morgan Stanley & Co. International plc
2025-10-21
7.19%
WILL FIELD CAPITAL PTE.LTD.
2025-10-21
7.83%→8.69%
Correction filing (name/detail fix only) — ratio carried over from the original filing
WILL FIELD CAPITAL PTE.LTD.
2025-10-21
7.83%→8.69%
Morgan Stanley MUFG Securities Co., Ltd.
2025-10-06
0.01%→0.31%
Morgan Stanley & Co. International plc
2025-09-19
5.18%→6.26%
WILL FIELD CAPITAL PTE.LTD.
2025-08-07
6.86%→7.83%
Morgan Stanley & Co. International plc
2025-08-06
5.20%→5.18%
Disclosures
No disclosures
Primary Source Filings
EDINET
2026-10-21
Large Shareholding Report
EDINET
2026-10-06
Large Shareholding Report
EDINET
2026-09-24
Large Shareholding Report
EDINET
2026-09-18
Large Shareholding Report
EDINET
2026-09-17
Large Shareholding Report
EDINET
2026-09-14
Large Shareholding Report
EDINET
2026-09-02
Large Shareholding Report
TDnet
2026-08-07
Q1 Earnings Flash
FY ending Mar 2027
EDINET
2026-07-22
Large Shareholding Report
EDINET
2026-07-17
Large Shareholding Report
EDINET
2026-07-15
Large Shareholding Report
EDINET
2026-07-14
Large Shareholding Report
EDINET
2026-06-25
Annual Securities Report
Period: Apr 2025 – Mar 2026
EDINET
2026-05-21
Large Shareholding Report
EDINET
2026-04-24
Large Shareholding Report
EDINET
2026-04-22
Large Shareholding Report
EDINET
2026-04-21
Large Shareholding Report
EDINET
2026-04-02
Large Shareholding Report
EDINETAmended
2026-03-26
Change Report
EDINET
2026-03-25
Large Shareholding Report
EDINET
2026-03-16
Large Shareholding Report
EDINET
2026-03-05
Large Shareholding Report
EDINET
2026-03-05
Large Shareholding Report
EDINET
2026-02-19
Large Shareholding Report
EDINET
2026-02-19
Large Shareholding Report
EDINET
2026-02-13
Large Shareholding Report
TDnet
2026-02-05
Q3 Earnings Flash
FY ending Mar 2026
EDINET
2026-02-05
Large Shareholding Report
EDINET
2026-01-23
Large Shareholding Report
EDINET
2026-01-21
Large Shareholding Report
Ask AI
I have this company's financials, ownership, and management on hand. Ask me anything from an M&A perspective.
End of Preview

Try the full product

Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.

Free Demo (No Time Limit, 10 Companies) →